BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11386503)

  • 1. Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis.
    Sharma RP; Martis B; Davis JM; Omens R; Janicak PG
    J Clin Psychopharmacol; 2001 Jun; 21(3):347-9. PubMed ID: 11386503
    [No Abstract]   [Full Text] [Related]  

  • 2. Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze.
    Schmitt U; Hiemke C
    Behav Brain Res; 2002 Jul; 133(2):391-4. PubMed ID: 12110474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze.
    Schmitt U; Hiemke C
    Behav Pharmacol; 1999 Mar; 10(2):131-7. PubMed ID: 10780826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic mechanisms of gabitril (tiagabine) and future potential developments.
    Meldrum BS; Chapman AG
    Epilepsia; 1999; 40 Suppl 9():S2-6. PubMed ID: 10612355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition.
    Schmitt U; Lüddens H; Hiemke C
    Pharmacol Biochem Behav; 2000 Feb; 65(2):351-6. PubMed ID: 10672990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(3)H]Tiagabine binding to GABA transporter-1 (GAT-1) in suicidal depression.
    Sundman-Eriksson I; Allard P
    J Affect Disord; 2002 Sep; 71(1-3):29-33. PubMed ID: 12167498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats.
    Schmitt U; Lüddens H; Hiemke C
    J Neural Transm (Vienna); 2002 May; 109(5-6):871-80. PubMed ID: 12111474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA-transporter.
    Thomsen C; Sørensen PO; Egebjerg J
    Br J Pharmacol; 1997 Mar; 120(6):983-5. PubMed ID: 9134205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia.
    Costa C; Leone G; Saulle E; Pisani F; Bernardi G; Calabresi P
    Stroke; 2004 Feb; 35(2):596-600. PubMed ID: 14726544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GABA transporter and its inhibitors.
    Soudijn W; van Wijngaarden I
    Curr Med Chem; 2000 Oct; 7(10):1063-79. PubMed ID: 10911018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]tiagabine binding to GABA uptake sites in human brain.
    Eriksson IS; Allard P; Marcusson J
    Brain Res; 1999 Dec; 851(1-2):183-8. PubMed ID: 10642842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of gamma-aminobutyric acid transport as experimental tools and therapeutic agents.
    Krogsgaard-Larsen P; Frølund BF; Falch E
    Methods Enzymol; 1998; 296():165-75. PubMed ID: 9779447
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2002 Jul; 176(1):193-202. PubMed ID: 12093096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
    Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A
    Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA transporters (GAT-1) in Alzheimer's disease.
    Nägga K; Bogdanovic N; Marcusson J
    J Neural Transm (Vienna); 1999; 106(11-12):1141-9. PubMed ID: 10651110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo labeling of the central GABA uptake carrier with 3H-Tiagabine.
    Suzdak PD; Swedberg MD; Andersen KE; Knutsen LJ; Braestrup C
    Life Sci; 1992; 51(24):1857-68. PubMed ID: 1333027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
    Borden LA; Murali Dhar TG; Smith KE; Weinshank RL; Branchek TA; Gluchowski C
    Eur J Pharmacol; 1994 Oct; 269(2):219-24. PubMed ID: 7851497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity at the GABA transporter contributes to acute cellular swelling produced by metabolic impairment in retina.
    Zeevalk GD; Nicklas WJ
    Vision Res; 1997 Dec; 37(24):3463-70. PubMed ID: 9425523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
    Eckstein-Ludwig U; Fei J; Schwarz W
    Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.